Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Nature Immunology|February 20, 2004
Cis association of Ly49A with MHC class I restricts natural killer cell inhibitionMarie-Agnès Doucey, Léonardo Scarpellino, Jacques Zimmer, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Soluble MHC-peptide complexes containing long rigid linkers abolish CTL-mediated cytotoxicityGeorgi S Angelov, Philippe Guillaume, Marek Cebecauer, et al.Immunology Letters|June 16, 2009
Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptorFrank Neumann, Christine Sturm, Martin Hülsmeyer, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2015
MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of AntibodiesGerhard Held, Immanuel F Luescher, Frank Neumann, et al.The Journal of Biological Chemistry|September 7, 2002
CD3 delta establishes a functional link between the T cell receptor and CD8Marie-Agnès Doucey, Laurence Goffin, Dieter Naeher, et al.Biophysical Journal|June 28, 2005
CD8 kinetically promotes ligand binding to the T-cell antigen receptorDmitry M Gakamsky, Immanuel F Luescher, Aladdin Pramanik, et al.The Journal of Experimental Medicine|September 8, 2010
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patientsJulien Fourcade, Zhaojun Sun, Mourad Benallaoua, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
The T cell receptor's alpha-chain connecting peptide motif promotes close approximation of the CD8 coreceptor allowing efficient signal initiationMichel Mallaun, Dieter Naeher, Mark A Daniels, et al.Seminars in Cancer Biology|March 6, 2004
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cellsDaniel E Speiser, Mikaël J Pittet, Donata Rimoldi, et al.Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoireJohan Verhagen, Raphaël Genolet, Graham J Britton, et al.Pageof 5